Recent developments in the production of human therapeutic proteins in eukaryotic algae
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Antibody-based therapeutics have had great success over the last few years, and continue to be one of the fastest growing sectors of drug development. The efficacy and specificity of antibody-based drugs makes them ideal candidates for new drug development, but the specificity of these drugs comes from their complexity, and this complexity makes antibodies very expensive to produce. To address this problem, the authors have developed a system for the expression of recombinant proteins using the unicellular eukaryotic green algae, Chlamydomonas reinhardtii. As proof of concept, the authors have engineered microalgae to produce several forms of a human IgA antibody directed against herpes simplex virus. The expression of human monoclonal antibodies in C. reinhardtii offers an attractive alternative to traditional mammalian-based expression systems, as both the plastid and nuclear genomes are easily and quickly transformed, and the production of proteins in algae has an inherently low cost of capitalisation and production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, L. L. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00137-4 · Cited by 229 · cited 1×
“Recombinant technologies, including phage display [1,2] and the generation of transgenic mice lines capable of expressing human immunological repertoires [3], have allowed for the rapid identification of antibodies capable of addressing an array of medical indications.”
Background
Cited by
Micro-algae come of age as a platform for recombinant protein production
Specht, E., Miyake-Stoner, S., & Mayfield, S. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0326-5 · Cited by 303
Self-citationRasala, B. A., Muto, M., Lee, P. A., Jager, M., Cardoso, R. M. F., Behnke, C. A., Kirk, P., Hokanson, C. A., Crea, R., Mendez, M., et al. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2010.00503.x · Cited by 270
Self-citationRobust expression of a bioactive mammalian protein in Chlamydomonas chloroplast
Manuell, A. L., Beligni, M. V., Elder, J. H., Siefker, D. T., Tran, M., Weber, A., McDonald, T. L., & Mayfield, S. P. (2007) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2007.00249.x · Cited by 154
Self-citationCorchero, J. L., Gasser, B., Resina, D., Smith, W., Parrilli, E., Vázquez, F., Abasolo, I., Giuliani, M., Jäntti, J., Ferrer, P., et al. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.09.001 · Cited by 133
Tools and Techniques for Chloroplast Transformation of Chlamydomonas
Purton, S. (2008) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-75532-8_4 · Cited by 93
Metadata
- Authors
- Franklin, S. E., & Mayfield, S. P.
- Venue
- Expert Opinion on Biological Therapy
- Publisher
- Informa Healthcare
- Published
- 2005-02
- Volume
- 5
- Issue
- 2
- Pages
- 225-235
- ISSN
- 1471-2598 (ISSN-L)
- 1744-7682
- OpenAlex
- W2155119422
- Cited by
- 92
- References
- 1
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.